Pulse Biosciences, Inc (PLSE) insider trading
Every open-market stock purchase and sale by Pulse Biosciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $26.6M over the last 12 months (4 buys).
- Insiders sold $3M over the last 12 months (4 sales).
- Last insider buy: Robert W Duggan (10% owner), $13M, 5 months ago.
Last 12 months: insiders bought $26.6M (4 buys) and sold $3M (4 sales). Last close $24.84 on Jun 7, 2026.
Recent PLSE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | Mahkam Zanganeh (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Robert W Duggan (10% owner) | Bought (not open market) | — |
| Jun 11, 2026 | Robert W Duggan (10% owner) | Bought (not open market) | — |
| Jun 11, 2026 | Maria Sainz (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Maria Sainz (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Manmeet Singh Soni (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Richard van den Broek (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Richard van den Broek (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Mahkam Zanganeh (Director) | Bought (not open market) | — |
| May 11, 2026 | Robert W Duggan (10% owner) | Bought | $13M |
| May 11, 2026 | Robert W Duggan (10% owner) | Bought | $13M |
| May 11, 2026 | Paul A Laviolette (CEO) | Bought | $295K |
| May 11, 2026 | Paul A Laviolette (CEO) | Bought | $295K |
| Mar 23, 2026 | Darrin Uecker (CTO) | Bought (not open market) | — |
| Feb 18, 2026 | Kevin Patrick Danahy (C-suite exec) | Sold | $118K |
| Feb 18, 2026 | Kevin Patrick Danahy (C-suite exec) | Bought (not open market) | — |
| Feb 17, 2026 | Kevin Patrick Danahy (C-suite exec) | Sold | $473K |
| Feb 17, 2026 | Kevin Patrick Danahy (C-suite exec) | Bought (not open market) | — |
| Feb 13, 2026 | Kevin Patrick Danahy (C-suite exec) | Sold | $471K |
| Feb 13, 2026 | Kevin Patrick Danahy (C-suite exec) | Bought (not open market) | — |
| Feb 12, 2026 | Kevin Patrick Danahy (C-suite exec) | Sold | $467K |
| Feb 12, 2026 | Kevin Patrick Danahy (C-suite exec) | Bought (not open market) | — |
| Feb 11, 2026 | Kevin Patrick Danahy (C-suite exec) | Sold | $504K |
| Feb 11, 2026 | Kevin Patrick Danahy (C-suite exec) | Bought (not open market) | — |
| Feb 10, 2026 | Kevin Patrick Danahy (C-suite exec) | Sold | $470K |
Who's trading PLSE
- Richard van den Broek, Director: other filings, last Jun 11, 2026
- Robert W Duggan, 10% owner: bought $26M (2 buys), last Jun 11, 2026
- Maria Sainz, Director: other filings, last Jun 11, 2026
- Manmeet Singh Soni, Director: other filings, last Jun 11, 2026
- Mahkam Zanganeh, Director: other filings, last Jun 11, 2026
- Paul A Laviolette, CEO: bought $591K (2 buys), last May 11, 2026
- Darrin Uecker, CTO: other filings, last Mar 23, 2026
- Kevin Patrick Danahy, C-suite exec: sold $3M (8 sales), last Feb 18, 2026
Get free alerts when an insider at Pulse Biosciences, Inc files a new trade →